Epidemiology of ST131 in Besançon University Hospital
Completed
- Conditions
- Escherichia Coli Infections
- Registration Number
- NCT02853708
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Brief Summary
The sequence type 131 (ST131) is a predominant lineage among extraintestinal pathogenic Escherichia coli. It plays a major role in the worldwide dissemination of E. coli that produce extended-spectrum beta-lactamase (ESBL). The aim of this study was to describe the epidemiology of ESBL producing ST131clonal group in our university hospital. All patients with an infection due to ESBL E. coli will be prospectively included for a 2-year period. ST131 isolates will be identified and risk factors associated to ST131 will be determined in comparison to non-ST131 ESBL E. coli.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Patients infected with ESBL producing E. coli
Exclusion Criteria
- Patients known to be carrier or infected in the previous year, patients only colonised with ESBL producing E. coli.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Risk factors associated to ESBL ST 131 infections up to 2 years Time of hospitalization
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centre Hospitalier Régional Universitaire
🇫🇷Besançon, France